Combination therapy under high and very high power short duration ablation: efficacy and safety evaluation

Combination therapy under high and very high power short duration ablation for the patients with atrial fibrillation: efficacy and safety evaluation - Atrial fibrillation ablation using high and very high power ablation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000054076

Enrollment

100

Registered

2024-05-12

Start date

2024-04-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

This group comprised of the patients who had undergone their first atrial fibrillation ablation using QDOT MICRO catheter under high and very high power ablation. This group comprised of the patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who had undergone their first catheter ablation in our institution.

Exclusion criteria

Exclusion criteria: Patients who could not obtain informed consent.

Design outcomes

Primary

Measure	Time frame
evaluation of Initial line isolation evaluation of stroke following catheter ablation	—

Secondary

Measure	Time frame
atrial fibrillation recurrence rate during 1 year follow-up period	—

Countries

Japan

Contacts

Public ContactTadashi Hoshiyama

Department of Cardiovascular medicine, Kumamoto University Hospital Cardiovascular medicine

tadashi@kumamoto-u.ac.jp096-373-5175

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026